<?xml version="1.0"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://www.novonordisk.com.mx/</loc></url><url><loc>https://www.novonordisk.com.mx/disease-areas.html</loc></url><url><loc>https://www.novonordisk.com.mx/disease-areas/type-1-diabetes.html</loc></url><url><loc>https://www.novonordisk.com.mx/disease-areas/type-2-diabetes.html</loc></url><url><loc>https://www.novonordisk.com.mx/disease-areas/obesity.html</loc></url><url><loc>https://www.novonordisk.com.mx/disease-areas/growth-disorders.html</loc></url><url><loc>https://www.novonordisk.com.mx/disease-areas/alzheimers-disease.html</loc></url><url><loc>https://www.novonordisk.com.mx/disease-areas/mash.html</loc></url><url><loc>https://www.novonordisk.com.mx/science-and-technology.html</loc></url><url><loc>https://www.novonordisk.com.mx/science-and-technology/our-scientific-approach.html</loc></url><url><loc>https://www.novonordisk.com.mx/sustainable-business.html</loc></url><url><loc>https://www.novonordisk.com.mx/sustainable-business/access-and-affordability.html</loc></url><url><loc>https://www.novonordisk.com.mx/sustainable-business/zero-environmental-impact.html</loc></url><url><loc>https://www.novonordisk.com.mx/sustainable-business/preventing-chronic-diseases.html</loc></url><url><loc>https://www.novonordisk.com.mx/careers.html</loc></url><url><loc>https://www.novonordisk.com.mx/careers/find-a-job.html</loc></url><url><loc>https://www.novonordisk.com.mx/careers/find-a-job/career-search-results.html</loc></url><url><loc>https://www.novonordisk.com.mx/careers/find-a-job/job-ad.html</loc></url><url><loc>https://www.novonordisk.com.mx/careers/job-agent.html</loc></url><url><loc>https://www.novonordisk.com.mx/careers/job-agent/job-email-unsubscribe.html</loc></url><url><loc>https://www.novonordisk.com.mx/careers/job-agent/thank-you-suscription.html</loc></url><url><loc>https://www.novonordisk.com.mx/careers/job-agent/unsubscription-confirmation.html</loc></url><url><loc>https://www.novonordisk.com.mx/careers/working-at-novo-nordisk.html</loc></url><url><loc>https://www.novonordisk.com.mx/careers/working-at-novo-nordisk/consent-declaration.html</loc></url><url><loc>https://www.novonordisk.com.mx/careers/event-calendar-meet-us.html</loc></url><url><loc>https://www.novonordisk.com.mx/about.html</loc></url><url><loc>https://www.novonordisk.com.mx/about/what-we-do.html</loc></url><url><loc>https://www.novonordisk.com.mx/about/who-we-are.html</loc></url><url><loc>https://www.novonordisk.com.mx/about/defeat-diabetes.html</loc></url><url><loc>https://www.novonordisk.com.mx/about/corona-virus-updates1.html</loc></url><url><loc>https://www.novonordisk.com.mx/search.html</loc></url><url><loc>https://www.novonordisk.com.mx/center-press.html</loc></url><url><loc>https://www.novonordisk.com.mx/center-press/2026/2026-18-05-novo-nordisk-presenta-nuevos-datos-sobre-semaglutida-en-mujeres-con-obesidad-y-tratamientos-de-perdida-de-peso-de-proxima-generacion.html</loc></url><url><loc>https://www.novonordisk.com.mx/center-press/2026/2026-06-04-semaglutida-7-2-mg-aprobado-en-estados-unidos-ofrece-una-perdida-de-peso-promedio-del-20-7-percenta.html</loc></url><url><loc>https://www.novonordisk.com.mx/center-press/2026/2026-13-04-semaglutida-oral-de-25mg-demostro-mayor-perdida-de-peso-que-orforglipron-y-menores-probabilidades-de-suspender-el-tratamiento-por-efectos-secundarios.html</loc></url><url><loc>https://www.novonordisk.com.mx/center-press/2026/2026-17-04-miles-de-personas-viven-con-hemofilia-sin-saberlo-una-realidad-global-que-tambien-afecta-a-mexico.html</loc></url><url><loc>https://www.novonordisk.com.mx/center-press/2026/2026-22-05-semaglutida-en-tableta-es-recomendado-por-el-comite-de-medicamentos-de-uso-humano-de-la-agencia-europea-de-medicamentos.html</loc></url><url><loc>https://www.novonordisk.com.mx/center-press/2026/2026-25-06-semaglutida-oral-supera-los-3-millones-de-prescripciones-aproximadamente-1-cada-5-segundos.html</loc></url><url><loc>https://www.novonordisk.com.mx/center-press/2026/2026-26-06-cagrisema-2-4-mg-de-novo-nordisk-demostro-una-reduccion-significativa-en-hba1c-y-peso-corporal.html</loc></url><url><loc>https://www.novonordisk.com.mx/center-press/2026/2026-29-06-novo-nordisk-abre-tienda-en-mercado-libre-mexico-para-ampliar-el-acceso-seguro-a-tratamientos-innovadores.html</loc></url><url><loc>https://www.novonordisk.com.mx/center-press/2026/2026-15-07-obesidades-y-novo-nordisk-presentan-la-primera-galeria-fotografica-sin-estigma-para-transformar-la-forma-en-que-se-habla-de-las-personas.html</loc></url><url><loc>https://www.novonordisk.com.mx/center-press/2026/2026-16-07-aprobacion-en-mexico-de-semaglutida-7-2-mg-wegovy-que-logra-una-perdida-de-peso-superior-al-25-percenta-en-1-de-cada-3-adultos.html</loc></url><url><loc>https://www.novonordisk.com.mx/center-press/2026/2026-17-08-la-primera-aprobacion-en-america-latina-para-semaglutida-oral-25-mg-wegovy-tabletas-marcando-una-nueva-era-en-el-manejo-oral-del-peso.html</loc></url><url><loc>https://www.novonordisk.com.mx/center-press/2026/2026-14-10-casi-29-mil-ninas-y-ninos-descubren-el-valor-de-la-alimentacion-saludable-cocinando-junto-a-novo-y-unicef.html</loc></url><url><loc>https://www.novonordisk.com.mx/contact-us.html</loc></url><url><loc>https://www.novonordisk.com.mx/contact-us/report-a-side-effect/report-side-effect-received.html</loc></url><url><loc>https://www.novonordisk.com.mx/insulin-100-years.html</loc></url></urlset>